scispace - formally typeset
G

Günther G. Steger

Researcher at Medical University of Vienna

Publications -  243
Citations -  11875

Günther G. Steger is an academic researcher from Medical University of Vienna. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 41, co-authored 238 publications receiving 10859 citations. Previous affiliations of Günther G. Steger include University of Vienna.

Papers
More filters
Journal ArticleDOI

Adjuvante Therapie des Kolorektalkarzinoms

Hugo Rainer, +3 more
- 01 Dec 1991 - 
TL;DR: Colorectal adenocarcinoma is the second most common solid tumor in Austria and radiotherapy has shown to reduce local recurrence in rectal cancer and chemotherapy (5-FU/levamisole) to improve the overall survival in subsets of coloreCTal cancer.
Journal ArticleDOI

Activity of T-DM1 in Her2-positive breast cancer brain metastases

Rupert Bartsch, +11 more
- 01 Sep 2014 - 
TL;DR: T-DM1 apparently offers relevant clinical activity in BM and further investigation is warranted; still, lapatinib plus capecitabine is currently the best established systemic therapy option.
Journal Article

Neoadjuvant chemotherapy of patients with breast carcinoma

Raimund Jakesz, +7 more
- 01 Jan 1998 - 
TL;DR: It is found that downstaging permits breast conservation in 60% of patients who would otherwise undergo mastectomy, and the significance of this method for further improvement of survival has to await results of ongoing trials.
Journal ArticleDOI

95 P - Preoperative, neoadjuvant chemotherapy leads to breast conserving surgery in locally advanced breast cancer

Michael Gnant, +5 more
- 01 Jan 1996 - 
TL;DR: Preoperative chemotherapy appears to be a valuable tool in the treatment of large breast cancers in order to allow breast conserving surgery in a substantial number of patients with T3/T4-tumors.
Journal ArticleDOI

Pharmacokinetics of 4'-O-tetrahydropyranyladriamycin given on a weekly schedule in patients with advanced breast cancer

Robert M. Mader, +7 more
- 01 Jan 1995 - 
TL;DR: The favorable ratio of the AUCs of THP-ADM and ADM after fractionation of THM suggests lower toxic side effects attributable to ADM, and this hypothesis was confirmed in a clinical study, where no severe cardiotoxicity and only mild alopecia were observed in 19 patients.